Overview

Study of TDM-180935 in Atopic Dermatitis Patients

Status:
COMPLETED
Trial end date:
2025-04-08
Target enrollment:
Participant gender:
Summary
Randomized, Vehicle-controlled, Parallel Group Study of TDM-180935 in Atopic Dermatitis Patients
Phase:
PHASE2
Details
Lead Sponsor:
Technoderma Medicines Inc.
Collaborator:
Therapeutics, Inc.